Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Implantable Neurostimulation Devices Market From 2025 To 2029?
The market for implantable neurostimulation devices has seen substantial growth recently. The market value is projected to increase from $8.68 billion in 2024 to $9.64 billion in 2025, representing a compound annual growth rate (CAGR) of 11.1%. This significant growth in the past can be linked to a rise in the demand for non-drug treatments, an increase in the preference for minimally invasive procedures, an expanding elderly population, a growing array of psychiatric disorders, and a heightened instance of chronic diseases.
What Is the Projected Market Size of the Implantable Neurostimulation Devices Market?
Expectations are high for a swift expansion in the implantable neurostimulation devices market within the coming years. Forecasts predict an upswing to $14.53 billion by 2029, indicative of a compound annual growth rate (CAGR) of 10.8%. Factors contributing to this projected growth during the forecast period are the increasing occurrence of neurological disorders, a surge in lifestyle diseases, escalating awareness, an upward trend in spinal cord injuries, and augmented healthcare expenditure. Some significant trends anticipated during the forecast period include the incorporation of sensing technology, progression in neurostimulation technologies, highly evolved product offerings, the inclusion of closed-loop systems, and the integration of wireless technology.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19520&type=smp
Who are the Major Competitors in the Implantable Neurostimulation Devices Market Outlook?
Major companies operating in the implantable neurostimulation devices market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Dignity Health, St. Jude Medical LLC, LivaNova PLC, Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., CURE Epilepsy, Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Pain Management NYC, Curonix LLC
What Is Fueling Growth in the Implantable Neurostimulation Devices Market?
The growth of the implantable neurostimulation device market is set to be driven by the increasing incidence of neurological disorders. These disorders, which can impact the structure or function of the nervous system, lead to a range of symptoms, including paralysis, seizures, and cognitive impairments. Greater detection rates of neurological disorders are being attributed to a higher exposure to risk factors such as high blood pressure, developmental anomalies, and trauma or injury. When other treatments prove insufficient or ineffective, implantable neurostimulation devices are used to moderate nerve activity and ease symptoms associated with neurological disorders. For instance, data from the Alzheimer’s Association, a non-profit health organization based in the US, suggests that around 6.9 million American seniors aged 65 and older are living with Alzheimer’s disease in 2024. Furthermore, 73% of this figure represents individuals aged 75 or older. This statistic is predicted to rise to 12.7 million by 2050. Hence, the increasing incidence of neurological disorders is expected to be a driving factor for the implantable neurostimulation device market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=19520&type=smp
Which Implantable Neurostimulation Devices Market Segments Are Growing the Fastest?
The implantable neurostimulation devicesmarket covered in this report is segmented –
1) By Type: Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Other Types
2) By Application: Pain Management, Parkinson’s Disease, Urinary And Fecal Incontinence, Epilepsy, Gastroparesis, Other Applications
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Spinal Cord Stimulation (SCS): Rechargeable SCS Devices, Non-Rechargeable SCS Devices
2) By Gastric Electric Stimulation (GES): Implantable Gastric Stimulators, Adjustable Gastric Stimulators
3) By Deep Brain Stimulation (DBS): DBS Devices for Movement Disorders, DBS Devices for Psychiatric Disorders
4) By Sacral Nerve Stimulation (SNS): SNS Devices for Urinary Incontinence, SNS Devices for Fecal Incontinence
5) By Vagus Nerve Stimulation (VNS): VNS Devices for Epilepsy, VNS Devices for Depression
6) By Other Types: Peripheral Nerve Stimulation (PNS), Cortical Stimulation Devices, Novel Neurostimulation Technologies
Which Industry Trends Are Shaping the Future of the Implantable Neurostimulation Devices Market?
Leading firms in the implantable neurostimulation devices market are striving to produce highly innovative products like spinal cord stimulation (SCS) systems to mitigate chronic pain. SCS systems are medical devices that employ electric impulses to control nerve activity in the spinal cord, which can alleviate persistent discomfort and enhance patients’ quality of life when other methods have failed. For example, in December 2022, U.S.-based medical device firm, Abbott, secured approval from the U.S. Food and Drug Administration (FDA) for its Eterna spinal cord stimulation (SCS) system. The Eterna SCS is currently the smallest implantable and rechargeable spinal cord stimulator in the market, designed for utmost daily ease. It incorporates Abbott’s unique BurstDR stimulation technology, believed to replicate natural brain firing sequences for enhanced pain relief and preferred by 87% of users over traditional tingling stimulation methods. With the fewest recharging necessities—requiring as little as five recharges per year due to Xtend energy technology, Eterna ensures ease of use. It is compatible with full-body MRI scans thanks to TotalScan technology and can adjust to future technological developments without the need for replacement. Additionally, Abbott’s integration of a mobile app allows for live monitoring of battery life and charging status on iPhone devices.
Access The Full Report Here:
Which Countries Are Leading the Implantable Neurostimulation Devices Market?
North America was the largest region in the implantable neurostimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19520
This Report Delivers Insight On:
1. How big is the implantable neurostimulation devices market, and how is it changing globally?
2. Who are the major companies in the implantable neurostimulation devices market, and how are they performing?
3. What are the key opportunities and risks in the implantable neurostimulation devices market right now?
4. Which products or customer segments are growing the most in the implantable neurostimulation devices market?
5. What factors are helping or slowing down the growth of the implantable neurostimulation devices market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
